150 related articles for article (PubMed ID: 23790244)
41. Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis.
Meyfroidt S; Van der Elst K; De Cock D; Joly J; Westhovens R; Hulscher M; Verschueren P
Patient Educ Couns; 2015 Mar; 98(3):384-90. PubMed ID: 25483574
[TBL] [Abstract][Full Text] [Related]
42. Differences between serum polar lipid profiles of male and female rheumatoid arthritis patients in response to glucocorticoid treatment.
Fu J; Cuppen BV; Welsing PM; van Wietmarschen H; Harms AC; Berger R; Koval S; Fritsch-Stork RD; Bijlsma JW; Hankemeier T; van der Greef J; Lafeber FP
Inflammopharmacology; 2016 Dec; 24(6):397-402. PubMed ID: 27682325
[TBL] [Abstract][Full Text] [Related]
43. Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapies.
Pincus T; Kavanaugh A; Sokka T
Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S2-11. PubMed ID: 15552508
[TBL] [Abstract][Full Text] [Related]
44. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
Da Silva JA; Jacobs JW; Kirwan JR; Boers M; Saag KG; Inês LB; de Koning EJ; Buttgereit F; Cutolo M; Capell H; Rau R; Bijlsma JW
Ann Rheum Dis; 2006 Mar; 65(3):285-93. PubMed ID: 16107513
[TBL] [Abstract][Full Text] [Related]
45. Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study.
Santiago T; Voshaar M; de Wit M; Carvalho PD; Buttgereit F; Cutolo M; Paolino S; Castelar Pinheiro GR; Boers M; Da Silva JAP
Rheumatology (Oxford); 2021 Jul; 60(7):3334-3342. PubMed ID: 33394036
[TBL] [Abstract][Full Text] [Related]
46. Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity.
Doumen M; Pazmino S; Bertrand D; Westhovens R; Verschueren P
Joint Bone Spine; 2023 May; 90(3):105491. PubMed ID: 36410680
[TBL] [Abstract][Full Text] [Related]
47. Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.
Jagpal A; Curtis JR
Drug Saf; 2018 Jun; 41(6):545-553. PubMed ID: 29392593
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review.
Sanmartí R; Tornero J; Narváez J; Muñoz A; Garmendia E; Ortiz AM; Abad MA; Moya P; Mateo ML; Reina D; Salvatierra-Ossorio J; Rodriguez S; Palmou-Fontana N; Ruibal-Escribano A; Calvo-Alén J
Reumatol Clin (Engl Ed); 2020; 16(3):222-228. PubMed ID: 30057295
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticoids in the treatment of early and late RA.
Bijlsma JW; Boers M; Saag KG; Furst DE
Ann Rheum Dis; 2003 Nov; 62(11):1033-7. PubMed ID: 14583563
[No Abstract] [Full Text] [Related]
50. [Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany].
Thiele K; Buttgereit F; Huscher D; Zink A;
Z Rheumatol; 2005 Apr; 64(3):149-54. PubMed ID: 15868331
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoid treatment in early rheumatoid arthritis.
Krause D; Rau R; Braun J
Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S121-5. PubMed ID: 22018197
[TBL] [Abstract][Full Text] [Related]
52. To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate.
Cutolo M; Shoenfeld Y; Bogdanos DP; Gotelli E; Salvato M; Gunkl-Tóth L; Nagy G
Autoimmun Rev; 2024 Jan; 23(1):103437. PubMed ID: 37652398
[TBL] [Abstract][Full Text] [Related]
53. Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review.
Ruyssen-Witrand A; Fautrel B; Saraux A; Le-Loët X; Pham T
Joint Bone Spine; 2010 May; 77(3):246-51. PubMed ID: 20451437
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoid-trials in rheumatoid arthritis mostly study representative real-world patients: A systematic review and meta-analysis.
Palmowski A; Nielsen SM; Buttgereit T; Palmowski Y; Boers M; Christensen R; Buttgereit F
Semin Arthritis Rheum; 2020 Dec; 50(6):1400-1405. PubMed ID: 32222381
[TBL] [Abstract][Full Text] [Related]
55. Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis.
Yu Z; Reynaud F; Lorscheider M; Tsapis N; Fattal E
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1630. PubMed ID: 32202079
[TBL] [Abstract][Full Text] [Related]
56. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses.
Dixon WG; Suissa S; Hudson M
Arthritis Res Ther; 2011 Aug; 13(4):R139. PubMed ID: 21884589
[TBL] [Abstract][Full Text] [Related]
57. The 70th anniversary of glucocorticoids in rheumatic diseases: the second youth of an old friend.
Palmowski Y; Buttgereit T; Buttgereit F
Rheumatology (Oxford); 2019 Apr; 58(4):580-587. PubMed ID: 29982743
[TBL] [Abstract][Full Text] [Related]
58. [Research progress of drugs commonly used to anti-rheumatoid arthritis].
Chi LQ; Zhou B; Gao WY; Liu Z
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2851-8. PubMed ID: 25423821
[TBL] [Abstract][Full Text] [Related]
59. The safety of low-dose glucocorticoids in rheumatic diseases: results from observational studies.
Hwang YG; Saag K
Neuroimmunomodulation; 2015; 22(1-2):72-82. PubMed ID: 25228230
[TBL] [Abstract][Full Text] [Related]
60. Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis.
Buttgereit F; Kvien TK
Rheumatology (Oxford); 2022 Dec; 62(1):35-41. PubMed ID: 35713511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
